# FIGHT-RP 1 Extension Study

> **NCT03999021** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 30 (estimated)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DRUG:** NAC effervescent tablets

## Key facts

- **NCT ID:** NCT03999021
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-24
- **Primary completion:** 2026-08
- **Final completion:** 2027-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03999021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03999021, "FIGHT-RP 1 Extension Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03999021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*